Vaccines, Blood & Biologics
STN: BL 125348/0
Proper Name: Laviv
Trade Name: Azficel-T
Manufacture: Fibrocell Technologies, Inc.
Indication: Indicated for improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults.
June 21, 2011 Approval Letter - Laviv
Indicated for improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults.
Summary Basis for Regulatory Action, June 20, 2011 - Laviv(PDF - 152KB) Approval History, Letters, Reviews, and Related Documents - Laviv
FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.